Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease

The pathogenic mechanisms underlying Batten disease are unclear. Patients uniformly possess autoantibodies against glutamic acid decarboxylase (GAD) that are predominantly reactive with a region of GAD (amino acids 1 to 20) distinct from subjects with autoimmune type 1 diabetes or stiff-person syndr...

Full description

Saved in:
Bibliographic Details
Published in:Neurology Vol. 64; no. 4; pp. 743 - 745
Main Authors: RAMIREZ-MONTEALEGRE, D, CHATTOPADHYAY, S, ATKINSON, M, PEARCE, D. A, CURRAN, T. M, WASSERFALL, C, PRITCHARD, L, SCHATZ, D, PETITTO, J, HOPKINS, D, SHE, J.-X, ROTHBERG, P. G
Format: Journal Article
Language:English
Published: Hagerstown, MD Lippincott Williams & Wilkins 22-02-2005
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The pathogenic mechanisms underlying Batten disease are unclear. Patients uniformly possess autoantibodies against glutamic acid decarboxylase (GAD) that are predominantly reactive with a region of GAD (amino acids 1 to 20) distinct from subjects with autoimmune type 1 diabetes or stiff-person syndrome. Batten patients did not possess autoantibodies against other type 1 diabetes-associated autoantigens and human leukocyte antigen genotypes revealed no specific associations with this disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0028-3878
1526-632X
DOI:10.1212/01.WNL.0000151973.08426.7E